Morgan Stanley Direct Lending's portfolio is growing and diversifying with an increase in investee companies. Click here to ...

In recent years, there has been a noted increase in the rates of chronic disease, as well as a growth in the number of ...

Jim Lacamp, Morgan Stanley Wealth Management senior vice president, joins CNBC's 'Money Movers' to discuss his outlook on the ...

The stock's fall snapped a four-day winning streak.

The Morgan Stanley executive is retiring to run a foundation she started that aims to bring more young women into wealth ...

In the most recent trading session, Morgan Stanley (MS) closed at $125.72, indicating a -0.02% shift from the previous trading day.

Individualized cancer vaccines and antibody-drug conjugates will be among the dominant biotech innovations in cancer next ...

Shares of Morgan Stanley MS shed 0.02% to $125.72 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.43% to 5,881.63 and Dow ...

Morgan Stanley analyst Terence Flynn notes that BioNTech (BNTX) announced last week that it had reached a settlement agreement with the National Institutes of Health and University of Pennsylvania ...

Morgan Stanley's strong Q3 performance saw a 17% non-interest revenue increase and a 37% rise in net income. Read more on the ...

Morgan Stanley has hired fund manager Abdulrahman Al-Abdulla as head of its business in Qatar, as the Wall Street bank ...

Morgan Stanley said Nvidia stock is its top pick heading into 2025, and success of Blackwell should dispel investors' ...